This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
BCL7A is silenced by hypermethylation to promote acute myeloid leukemia
Biomarker Research Open Access 20 March 2023
-
SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
Molecular Cancer Open Access 21 February 2023
-
The chromatin remodeling subunit Baf200 promotes normal hematopoiesis and inhibits leukemogenesis
Journal of Hematology & Oncology Open Access 26 February 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Corey SJ, Minden MD, Barber DL, Kantarjian H, Wang JC, Schimmer AD . Myelodysplastic syndromes: the complexity of stem-cell diseases. Nat Rev Cancer 2007; 7: 118–129.
Haferlach T, Nagata Y, Grossmann V, Okuno Y, Bacher U, Nagae G et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia 2014; 28: 241–247.
Papaemmanuil E, Gerstung M, Malcovati L, Tauro S, Gundem G, Van Loo P et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 2013; 122: 3616–3627.
Makishima H, Yoshizato T, Yoshida K, Sekeres MA, Radivoyevitch T, Suzuki H et al. Dynamics of clonal evolution in myelodysplastic syndromes. Nat Genet 2017; 49: 204–212.
Li M, Zhao H, Zhang X, Wood LD, Anders RA, Choti MA et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet 2011; 43: 828–829.
Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP et al. A landscape of driver mutations in melanoma. Cell 2012; 150: 251–263.
Yoshikawa Y, Sato A, Tsujimura T, Otsuki T, Fukuoka K, Hasegawa S et al. Biallelic germline and somatic mutations in malignant mesothelioma: multiple mutations in transcription regulators including mSWI/SNF genes. Int J Cancer 2015; 136: 560–571.
Mehra R, Vats P, Kalyana-Sundaram S, Udager AM, Roh M, Alva A et al. Primary urethral clear-cell adenocarcinoma: comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing. Am J Pathol 2014; 184: 584–591.
Manceau G, Letouze E, Guichard C, Didelot A, Cazes A, Corte H et al. Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma. Int J Cancer 2013; 132: 2217–2221.
Buscarlet M, Krasteva V, Ho L, Simon C, Hebert J, Wilhelm B et al. Essential role of BRG, the ATPase subunit of BAF chromatin remodeling complexes, in leukemia maintenance. Blood 2014; 123: 1720–1728.
Shi J, Whyte WA, Zepeda-Mendoza CJ, Milazzo JP, Shen C, Roe JS et al. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Genes Dev 2013; 27: 2648–2662.
Madan V, Shyamsunder P, Han L, Mayakonda A, Nagata Y, Sundaresan J et al. Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia. Leukemia 2016; 30: 1672–1681.
Roberts CW, Orkin SH . The SWI/SNF complex—chromatin and cancer. Nat Rev Cancer 2004; 4: 133–142.
Wilson BG, Roberts CW . SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 2011; 11: 481–492.
Neely KE, Workman JL . Histone acetylation and chromatin remodeling: which comes first? Mol Genet Metab 2002; 76: 1–5.
Acknowledgements
This work was supported by the National Institutes of Health (NIH, Bethesda, MD, USA) Grants RO1HL-082983 (to JPM), U54 RR019391 (to JPM), K24 HL-077522 (to JPM), a grant from the AA & MDS International Foundation (Rockville, MD, USA, to JPM and Cleveland OH, USA, to HM), the Robert Duggan Charitable Fund (Cleveland, OH, USA, to JPM), a grant from Edward P Evans Foundation (Cleveland, OH, USA, to JPM and MAS), Scott Hamilton CARES grant (Cleveland, OH, USA, to HM), Grant-in-Aids from the Ministry of Health, Labor and Welfare of Japan and KAKENHI (23249052, 22134006 and 21790907) (Tokyo, Japan, to SO) (15km0305018h0101, 16km0405110h0004 and 16H05338) (Kyoto, Japan, to HM), project for development of innovative research on cancer therapies (p-direct) (Tokyo, Japan, to SO), the Japan Society for the Promotion of Science (JSPS) through the ‘Funding Program for World-Leading Innovative R&D on Science and Technology’, initiated by the Council for Science and Technology Policy (CSTP) (Tokyo, Japan, to SO), project for cancer research and therapeutics evolution (P-CREATE) from Japan Agency for Medical Research and Development 16cm0106501h0001 (Kyoto Japan, to SO) and 16cm0106422h0001 (Kyoto Japan, to TY), National Aeronautics and Space Administration Grant NNJ13ZSA001N (Cleveland, OH, USA, to TR.) and a grant from The YASUDA Medical Foundation (Kyoto Japan, to HM). The results published here were partly based on data generated by The Cancer Genome Atlas pilot project established by the National Cancer Institute and National Human Genome Research Institute.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Sakai, H., Hosono, N., Nakazawa, H. et al. A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasia. Leukemia 32, 839–843 (2018). https://doi.org/10.1038/leu.2017.319
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2017.319
This article is cited by
-
BCL7A is silenced by hypermethylation to promote acute myeloid leukemia
Biomarker Research (2023)
-
SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
Molecular Cancer (2023)
-
The chromatin remodeling subunit Baf200 promotes normal hematopoiesis and inhibits leukemogenesis
Journal of Hematology & Oncology (2018)